Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about

< Previous 1 2 3 Next >
U.S. RESEARCH ROUNDUP-Weatherford, General Motors, Endo International
May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Total System Services, Ubiquiti Networks and Advance Auto Parts, on... 
Tags companyNews
From Reuters: Company News
Biggest Movers in Manufacturing Stocks Now – ROCK CLLS FOE AVXS
 
Tags NASDAQ:DMTX NASDAQ:AAVL NASDAQ:RXDX
From InvestorPlace
Implied IUSG Analyst Target Price: $91
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Avalanche Biotechnologies Q1 loss per share $0.57
* Avalanche Biotechnologies, Inc. Reports first quarter 2016 financial results 
Tags companyNews
From Reuters: Company News
Commit To Buy Avalanche Biotechnologies At $5, Earn 24.1% Annualized Using Options
Investors eyeing a purchase of Avalanche Biotechnologies, Inc. (AAVL) stock, but cautious about paying the going market price of $5.51/share, might benefit from considering selling puts among the... 
Tags Stocks
From Market News Video
18 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:BLUE NASDAQ:CBIO NASDAQ:ADXS
From InvestorPlace
Look Under The Hood: IBB Has 56% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Avalanche Posts Wider-than-Expected 4Q Loss
Being a development-stage company, Avalanche does not have any approved product in its portfolio yet. In this scenario, investors are expected to keep an eye on pipeline development at the company,... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
How The Parts Add Up: UWM Headed For $78
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Hottest Manufacturing Stocks Now – TWI BRCD XENE TTPH
 
Tags NASDAQ:TCON NYSE:SSNI NASDAQ:AAON
From InvestorPlace
Dozens of biotech companies are ‘free’ for investors’ taking
They’re trading at less than net cash, making them bargains — and also risky, so buyer beware, says Michael Brush. 
Tags AAVL RHHBY TMSEX
From MarketWatch
Biggest Movers in Manufacturing Stocks Now – COLL EDGE ASMB HPJ
 
Tags NASDAQ:OASM Hot Stocks NYSE:WAB
From InvestorPlace
40 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:BIIB NASDAQ:HTBX :ATNM
From InvestorPlace
Benzinga's M&A Chatter for Monday February 1, 2015
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday February 1, 2015: Abbott to Acquire Alere ... 
Tags Benzinga KUTV Electronic Equipment Manufacturers
From Benzinga
Avalance Biotechnologies Tumbles 14% Following Acquisition Announcement
Shares of Avalanche Biotechnologies Inc (NASDAQ: AAVL) plunged to a new 52-week low of $5.07 on Monday and was trading lower by more ... 
Tags M&A AAVL Movers
From Benzinga
Stocks Hitting 52-Week Lows
Ability Inc (NASDAQ: ABIL) shares fell 7.60 percent to touch a new 52-week low of $7.90. Ability shares have declined 13.14 percent ... 
Tags Benzinga AAVL LGF
From Benzinga
Commit To Buy Avalanche Biotechnologies At $5, Earn 20.3% Annualized Using Options
Investors eyeing a purchase of Avalanche Biotechnologies, Inc. (AAVL) shares, but cautious about paying the going market price of $6.20/share, might benefit from considering selling puts among the... 
Tags Stocks
From Market News Video
16 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:AAVL NASDAQ:BCLI NASDAQ:KIN
From InvestorPlace
Noteworthy Wednesday Option Activity: FTK, SMTC, AAVL
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Flotek Industries Inc (FTK), where a total of 38,513 contracts have traded so far,... 
Tags Stocks
From Market News Video
5 Biotechs That Can Win From Ophthalmology Innovation
Joshua Schimmer, MD of Piper Jaffray attended the Ophthalmology Innovation Summit (OIS) and was "impressed" with the improving basic ... 
Tags Analyst Ratings Top Stories RGNX
From Benzinga
Biggest Movers in Manufacturing Stocks Now – TROV AGTC ACW VBIV
 
Tags NASDAQ:TROV NASDAQ:NVET NASDAQ:PRCP
From InvestorPlace
GenSight Biologics IPO
GenSight is a smaller size biotech deal with Leerick, Evercore and Canaccord on the cover. The 4.6M shares are all primary with a $14 mid-point. Post-IPO there will be close to 19M shares with a market... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Biggest Movers in Manufacturing Stocks Now – SAGE CHRS AAVL FBIO
 
Tags NASDAQ:ZSAN AMEX:SKY NASDAQ:EPRS
From InvestorPlace
Spark Therapeutics Reports Positive Phase 3 Results In Patients With Rare Blindness
Shares of Spark Therapeutics ended the day up 25% after reporting positive phase 3 results for its SPK-RPE65 gene therapy. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Uncertainty Weighs Down On The Market - Markets This Morning
The factors that set this bear market in motion – cuts in margin debt, low commodity prices, Chinese uncertainty – remain in place. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Avalanche Biotechnologies Becomes Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Avalanche Announces Phase 2 Wet AMD Trial Headed Back To The Lab
Shares of Avalanche tumbled today 27% after the company reported that it won't advance its phase 2 AVA-101 Wet AMD gene therapy treatment for the time being 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Avalanche abandons Phase 2b plans
Avalanche Biotechnologies Inc. (Nasdaq: AAVL) widened second quarter losses and announced that it will not initiate a Phase 2b clinical trial of AVA-101 in the second half of 2015. The stock price... 
From MarketMinute.com Stock News
Another Landslide In Avalanche Biotech
Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show. Avalanche Biotechnologies Inc ... 
Tags Intraday Update premarkt outlook Benzinga
From Benzinga
Avalanche Biotechnologies (AAVL) Plummets on Q2 Loss
Avalanche Biotechnologies Inc (NASDAQ: AAVL) shares dropped 28.2% to $9.93. Avalanche reported a Q2 loss of $0.38 per share on revenue of $279,000 and issued an update on AVA-101 program. Share volume... 
From Baystreet.ca RSS Feed
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.